Analyze Diet
Frontiers in veterinary science2026; 13; 1884314; doi: 10.3389/fvets.2026.1884314

Reference interval for serum amyloid a in apparently healthy donkeys measured with a donkey-specific ELISA.

Abstract: Serum amyloid A (SAA) is a major acute phase protein used as an inflammatory biomarker in equine medicine. However, no universally accepted assay-specific reference interval (RI) exists for donkeys, and available literature remains limited, with only few studies using different donkey breeds and immunoassay platforms. This study aimed to establish an assay- and population-specific RI for serum SAA in apparently healthy donkeys using a species-specific double sandwich ELISA. Unassigned: Serum SAA concentrations were measured in 176 apparently healthy donkeys. RI estimation followed ASVCP/CLSI recommendations. The primary RI was calculated nonparametrically as the central 95% interval from all reference individuals, and two-sided 90% confidence intervals (CIs) for the reference limits were estimated nonparametrically. Data were inspected using Tukey's interquartile fences; however, high-end observations were not excluded from the primary RI analysis. Exploratory analyses were performed to assess the need for partitioning by sex, age, or breed. Unassigned: The nonparametric RI for serum SAA was 2.91-42.85 ng/mL. The 90% CI for the lower reference limit was 0.00-4.07 ng/mL, and the 90% CI for the upper reference limit was 35.49-67.10 ng/mL. Exploratory analyses did not support partitioning by sex, age, or breed. The relatively broad CI for the upper reference limit indicated imprecision, likely reflecting the influence of a minority of high-end observations. Unassigned: The low SAA concentrations observed in this study are consistent with findings reported in horses. Differences between this and previous donkey studies may reflect variation in assay platform, sample size, management conditions, physiological state, or population characteristics. Because SAA is a rapidly responsive acute phase protein, the proposed interval should be interpreted as an assay- and population-specific RI rather than as a disease-classification decision limit. Clinical interpretation should therefore always consider the individual donkey's clinical context.
Publication Date: 2026-07-13 PubMed ID: 42516301PubMed Central: PMC13402198DOI: 10.3389/fvets.2026.1884314Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study established a reference interval (RI) for serum amyloid A (SAA) levels in healthy donkeys using a donkey-specific ELISA assay to improve the accuracy of inflammatory biomarker interpretation in equine medicine.
  • The research provides an assay- and population-specific baseline of SAA concentrations, allowing better clinical decision-making regarding inflammation in donkeys.

Background

  • Serum amyloid A (SAA): A major acute phase protein used as a biomarker for inflammation in horses and donkeys.
  • Importance of Reference Interval (RI): Clinicians rely on RIs to differentiate between healthy and diseased states based on biomarker levels.
  • Current Gap: No universally accepted, assay-specific RI for SAA in donkeys exists; previous studies used various breeds and assays, leading to inconsistent data.

Study Objectives and Design

  • To establish an assay- and population-specific RI for serum SAA in apparently healthy donkeys.
  • Used a species-specific double sandwich ELISA tailored for donkeys to measure serum SAA concentrations, ensuring assay specificity.
  • Sample included 176 apparently healthy donkeys, encompassing diverse ages, sexes, and breeds.
  • RI estimation followed established veterinary guidelines (ASVCP/CLSI), using nonparametric methods to determine the central 95% interval (2.5th to 97.5th percentile).
  • Two-sided 90% confidence intervals (CIs) were computed for the reference limits to assess statistical precision.
  • Data were inspected for outliers using Tukey’s interquartile fences, but high-end values were retained to reflect true population variance.
  • Exploratory analyses investigated whether RI partitioning was warranted based on sex, age, or breed differences.

Key Findings

  • The established nonparametric RI for serum SAA concentrations in donkeys was 2.91 to 42.85 ng/mL.
  • The 90% CI for the lower reference limit ranged from 0.00 to 4.07 ng/mL.
  • The 90% CI for the upper reference limit was wider, at 35.49 to 67.10 ng/mL, indicating some imprecision, likely due to a few high SAA values in the dataset.
  • No statistically significant need was found to partition the RI by sex, age, or breed, suggesting the interval applies broadly across these variables in donkeys.
  • The relatively low SAA concentrations align closely with previous findings observed in horses, reinforcing species similarities.

Interpretation and Significance

  • Differences between this study’s RI and those from earlier donkey research likely result from variations in assay platforms, sample sizes, donkey management, physiological conditions, or population profiles.
  • SAA is a highly dynamic acute phase protein that can rapidly increase during inflammation, so the presented RI should be viewed as an assay- and population-specific baseline rather than strict disease thresholds.
  • Clinical decisions should always consider the individual donkey’s health status and contextual factors in addition to serum SAA levels.
  • This donkey-specific assay and RI provide veterinarians with a more tailored and reliable tool to interpret SAA measurements for health monitoring and disease detection in donkeys.

Conclusion

  • The study successfully established a donkey-specific reference interval for serum amyloid A using a species-specific ELISA, improving the clinical utility of SAA as an inflammatory biomarker in donkeys.
  • The results emphasize the importance of assay- and population-specific RIs rather than relying on universal values derived from different species or assays.
  • The provided RI supports better differentiation of normal versus elevated SAA levels in healthy donkeys, enhancing disease monitoring and veterinary care.

Cite This Article

APA
Perzyna M, Bardet E, Baranowska K, Kiełbik P, Puchalska M, Pawliński B, Witkowska-Piłaszewicz O. (2026). Reference interval for serum amyloid a in apparently healthy donkeys measured with a donkey-specific ELISA. Front Vet Sci, 13, 1884314. https://doi.org/10.3389/fvets.2026.1884314

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 13
Pages: 1884314
PII: 1884314

Researcher Affiliations

Perzyna, Maciej
  • Department of Large Animals Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.
Bardet, Edith
  • Scientific Society of Veterinary Medicine Students, Warsaw University of Life Sciences, Warsaw, Poland.
Baranowska, Katarzyna
  • Scientific Society of Veterinary Medicine Students, Warsaw University of Life Sciences, Warsaw, Poland.
Kiełbik, Paula
  • Department of Large Animals Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.
Puchalska, Maria
  • Department of Pathology and Veterinary Diagnostic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.
Pawliński, Bartosz
  • Department of Large Animals Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.
Witkowska-Piłaszewicz, Olga
  • Department of Large Animals Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.

Conflict of Interest Statement

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 31 references
  1. Burden F, Thiemann A. Donkeys are different.. J Equine Vet Sci (2015) 35:376–82.
  2. Masebo NT, Benedetti B, Angeloni MG, Lee L, Bigi D, Padalino B. Systematic literature review on donkeys (): husbandry and welfare in Europe.. Animals (2025) 15:2768.
    doi: 10.3390/ani15192768pmc: PMC12523398pubmed: 41096364google scholar: lookup
  3. Zhu Q, Khan MZ, Jing Y, Geng M, Zhang X, Zheng Y. The donkey genome: from evolutionary insights to sustainable breeding strategies.. Animals (2026) 16:93.
    doi: 10.3390/ani16010093pmc: PMC12784754pubmed: 41514782google scholar: lookup
  4. Geiger M, Hockenhull J, Buller H, Tefera Engida G, Getachew M, Burden FA. Understanding the attitudes of communities to the social, economic, and cultural importance of working donkeys in rural, Peri-urban, and urban areas of Ethiopia.. Front Vet Sci (2020) 7:7.
    doi: 10.3389/fvets.2020.00060pmc: PMC7033506pubmed: 32118074google scholar: lookup
  5. Cameron A, Freeman SL, Wild I, Burridge J, Burrell K. Scoping review of the socioeconomic value of working equids, and the impact of educational interventions aimed at improving their welfare.. Animals (2026) 16:165.
    doi: 10.3390/ani16020165pmc: PMC12837931pubmed: 41594356google scholar: lookup
  6. Kithuka JM, Wachira TM, Ngetich W, Onono JO. Characterising donkey welfare challenges and opportunities associated with human activities and environmental factors in seven Kenyan counties.. Anim Welf (2026) 35:e5.
    doi: 10.1017/awf.2025.10057pmc: PMC12817226pubmed: 41567521google scholar: lookup
  7. Rickards K, Toribio RE. Clinical insights: recent advances in donkey medicine and welfare.. Equine Vet J (2021) 53:859–62.
    doi: 10.1111/evj.13471pubmed: 34355829google scholar: lookup
  8. Thiemann A, Fernandez EB, Rickards K, Harrison A. Assessing quality of life and welfare of donkeys in the UK.. In Pract (2018) 40:249–57.
    doi: 10.1136/inp.k2584google scholar: lookup
  9. Gichure MN, Olayide O. Selected intervention strategies to improve health and welfare of working donkeys in Kenya: a narrative review.. Asian J Res Anim Vet Sci (2024) 7:69–82.
  10. Kay G, Tligui N, Semmate N, Azrib R, González FJN, Brizgys L. Determining factors and interspecific modeling for serum amyloid a concentrations in working horses, donkeys, and mules.. Res Vet Sci (2019) 125:256–65.
    doi: 10.1016/j.rvsc.2019.07.004pubmed: 31325640google scholar: lookup
  11. Samimi AS, Samimi K, Karimiafshar M, Tajik J. Comparative anti-inflammatory effects of insulin and Flunixin on acute-phase responses and cardiovascular biomarkers during inflammatory phase in miniature donkeys.. J Equine Vet Sci (2019) 81:102788.
    doi: 10.1016/j.jevs.2019.102788pubmed: 31668307google scholar: lookup
  12. El-Ashker MR, El-Sebaei MG, Aamer HG. The influence of experimentally-induced endotoxaemia on clinical variables and markers of systemic inflammation in donkeys ().. Vet Med (Praha) (2017) 62:117–24.
    doi: 10.17221/133/2016-VETMEDgoogle scholar: lookup
  13. Abdullah M. Acute phase proteins in veterinary medicine: a review.. J Anim Sci Vet Med (2021) 6:188–94.
    doi: 10.31248/JASVM2020.216google scholar: lookup
  14. Jerele S, Davis E, Mapes S, Pusterla N, Navas González FJ, Iglesias Pastrana C. Survey of serum amyloid a and bacterial and viral frequency using qPCR levels in recently captured feral Donkeys from Death Valley National Park (California).. Animals (2020) 10:1086.
    doi: 10.3390/ani10061086pmc: PMC7341296pubmed: 32585994google scholar: lookup
  15. Witkowska-Piłaszewicz OD, Żmigrodzka M, Winnicka A, Miśkiewicz A, Strzelec K. Serum amyloid a in equine health and disease.. Equine Vet J (2019) 51:293–8.
    doi: 10.1111/evj.13062pmc: PMC7163734pubmed: 30565319google scholar: lookup
  16. Jacobsen S. Use of serum amyloid a in equine medicine and surgery.. Vet Clin Pathol (2023) 52:8–18.
    doi: 10.1111/vcp.13195pubmed: 36336845google scholar: lookup
  17. Dondi F, Lukacs RM, Gentilini F, Rinnovati R, Spadari A, Romagnoli N. Serum amyloid a, haptoglobin, and ferritin in horses with colic: association with common clinicopathological variables and short-term outcome.. Vet J (2015) 205:50–5.
    doi: 10.1016/j.tvjl.2015.03.015pubmed: 25981935google scholar: lookup
  18. Vandenplas ML, Moore JN, Barton MH, Roussel AJ, Cohen ND. Concentrations of serum amyloid a and lipopolysaccharide-binding protein in horses with colic.. Am J Vet Res (2005) 66:1509–16.
    doi: 10.2460/ajvr.2005.66.1509pubmed: 16261823google scholar: lookup
  19. Ludwig EK, Brandon Wiese R, Graham MR, Tyler AJ, Settlage JM, Werre SR. Serum and synovial fluid serum amyloid a response in equine models of synovitis and septic arthritis.. Vet Surg (2016) 45:859–67.
    doi: 10.1111/vsu.12531pubmed: 27580707google scholar: lookup
  20. Yoshimura S, Koziy RV, Dickinson R, Moshynskyy I, McKenzie JA, Simko E. Use of serum amyloid a in serum and synovial fluid to detect eradication of infection in experimental septic arthritis in horses.. Can J Vet Res (2020) 84:198–204.
    pmc: PMC7301682pubmed: 32801454
  21. Perez-Ecija A, Buzon-Cuevas A, Aguilera-Aguilera R, Gonzalez-De Cara C, Mendoza Garcia FJ. Reference intervals of acute phase proteins in healthy Andalusian donkeys and response to experimentally induced endotoxemia.. J Vet Intern Med (2021) 35:580–9.
    doi: 10.1111/jvim.16015pmc: PMC7848381pubmed: 33336874google scholar: lookup
  22. Bazzano M, Bonfili L, Eleuteri AM, Serri E, Scollo C, Yaosen Y. Assessment of serum amyloid a concentrations and biochemical profiles in lactating jennies and newborn Ragusano donkey foals around parturition and one month after foaling in Sicily.. Reprod Dom Anim (2022) 57:262–8.
    doi: 10.1111/rda.14048pmc: PMC9300177pubmed: 34816505google scholar: lookup
  23. Satué K, Calvo A, Gardón J. Factors influencing serum amyloid type a (SAA) concentrations in horses.. Open J Vet Med (2013) 3:58–66.
    doi: 10.4236/ojvm.2013.31010google scholar: lookup
  24. Tharwat M, Al-Sobayil F, Ali H. Changes in the hematobiochemical, acid-base and blood gas elements as well as biomarkers of inflammation and bone metabolism in donkeys () with acute bleeding.. Open Vet J (2024) 14:1146–53.
    doi: 10.5455/OVJ.2024.v14.i5.8pmc: PMC11199747pubmed: 38938441google scholar: lookup
  25. Friedrichs KR, Harr KE, Freeman KP, Szladovits B, Walton RM, Barnhart KF. ASVCP reference interval guidelines: determination of de novo reference intervals in veterinary species and other related topics.. Vet Clin Pathol (2012) 41:441–53.
    doi: 10.1111/vcp.12006pubmed: 23240820google scholar: lookup
  26. Mea ER. Gentamicin-induced acute kidney injury in equines is associated with marked acute phase response: an experimental study on donkey ().. J Vet Sci Med Diagn (2015) 4.
    doi: 10.4172/2325-9590.1000154google scholar: lookup
  27. Souto P, Santos M, Orozco A, Souto PC, Santos MR, Orozco AMO. Enzyme-linked immunosorbent assay (ELISA) development for equine serum amyloid a (SAA) determination using recombinant proteins.. Methods Protoc (2025) 8, 1–13.
    doi: 10.3390/mps8020037pmc: PMC12029847pubmed: 40278511google scholar: lookup
  28. Cray C. Acute phase proteins in animals.. Prog Mol Biol Transl Sci (2012) 105:113–50.
  29. Jacobsen S, Vinther AM, Kjelgaard-Hansen M, Nielsen LN. Validation of an equine serum amyloid a assay with an unusually broad working range.. BMC Vet Res (2019) 15:462.
    doi: 10.1186/s12917-019-2211-3pmc: PMC6923866pubmed: 31856804google scholar: lookup
  30. Goodrich EL, Behling-Kelly E. Clinical pathology of donkeys and mules.. Vet Clin North Am Equine Pract (2019) 35:433–55.
    doi: 10.1016/j.cveq.2019.08.002pubmed: 31672198google scholar: lookup
  31. Bazzano M, Marchegiani A, Troisi A, McLean A, Laus F. Serum amyloid a as a promising biomarker in domestic animals’ reproduction: current knowledge and future perspective.. Animals (2022) 12:589.
    doi: 10.3390/ani12050589pmc: PMC8909795pubmed: 35268158google scholar: lookup

Citations

This article has been cited 0 times.